Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Basel A. Abushullaih"'
Autor:
Nasir Khalid Amra, Salwa Shaberdeen Sheikh, Basel A Abushullaih, Nafeesa A Al-Faris, Adil A Al-Khatti, Huda H Al-Sayed
Publikováno v:
Journal of Applied Hematology, Vol 7, Iss 1, Pp 17-23 (2016)
Background and Objectives: Minimal residual disease (MRD) assays for monitoring acute lymphoblastic leukemia (ALL) during treatment are defined as assays with a limit of detection of at least 0.01% leukemic blasts per mononuclear cells or total nucle
Externí odkaz:
https://doaj.org/article/1cf976696a5f49f9a98ba380d046a979
Autor:
Basel A. Abushullaih, Deepthi Jayawardene, Carl W. Jackson, Najat C. Daw, Deo Kumar Srivastava, Paula E. Stenberg, Julie T. Arnold, Melanie M. White
Publikováno v:
Blood. 91:466-474
The thrombopoietic efficacy of recombinant forms of c-mplligand is being actively investigated in preclinical studies using daily dosing schedules. However, a comprehensive kinetic study of the thrombopoietic response to a single injection of recombi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3413951417f511ba85b1c2b56c35d5d
https://doi.org/10.1182/blood.v91.2.466.466_466_474
https://doi.org/10.1182/blood.v91.2.466.466_466_474
Publikováno v:
Experimental hematology. 29(12)
Objective To determine a thrombopoietin schedule that would effectively enhance hematopoiesis and prevent death in mice after lethal myelosuppression. Methods First, we determined whether recombinant Mpl ligand (Mpl-L) has a priming effect on thrombo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d980547a32637991e3b3b3951c52f8c8
https://pubmed.ncbi.nlm.nih.gov/11750101
https://pubmed.ncbi.nlm.nih.gov/11750101